CALLED the N-ICE Trial, Australian researchers are investigating if N-Acetyl Cysteine, or NAC, can reduce cravings for ice (crystal methamphetamine) and help people stop using the substance, the Curtin University National Drug Research Institute (NDRI) has announced.
The N-ICE Trial is being conducted at frontline clinical services in Wollongong, Geelong and Melbourne.
Lead researcher and NDRI Associate Professor Rebecca McKetin said previous studies showed NAC could reduce cravings for methamphetamine use and other substances including cocaine, cannabis and tobacco.
Further information about participation in the trial can be found at nicetrial.info.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Jul 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Jul 18
